Skip to content

Clinical trials

Phase 2 Autistic Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 2 Country / region: United States Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20031
20042
20054
20064
20072
20087
20094
20103
20118
201210
20134
20146
20166
20173
20183
20194
20203
20211
20223
20236
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Recruiting9
Terminated7
Active, not recruiting5
Withdrawn4
Unknown status3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University10
Forest Laboratories5
University of North Carolina, Chapel Hill5
National Institute of Mental Health (NIMH)4
Arizona State University3
Neuren Pharmaceuticals Limited3
Seaside Therapeutics, Inc.3
Drexel University College of Medicine2
Evdokia Anagnostou2
Joanne Kurtzberg, MD2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder95
Autism Spectrum Disorder48
Asperger Syndrome14
Child Development Disorders, Pervasive12
Anxiety Disorders5
Fragile X Syndrome4
Epilepsy3
Ataxia2
Bipolar Disorder2
Brain Diseases2

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.